MARCHESINI REGGIANI, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 15.999
EU - Europa 11.753
AS - Asia 3.479
AF - Africa 639
SA - Sud America 49
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.935
Nazione #
US - Stati Uniti d'America 15.967
GB - Regno Unito 3.738
IT - Italia 1.905
DE - Germania 1.648
CN - Cina 1.376
SE - Svezia 1.147
VN - Vietnam 1.050
UA - Ucraina 981
IN - India 712
FR - Francia 552
IE - Irlanda 528
RU - Federazione Russa 455
EE - Estonia 274
ZA - Sudafrica 254
BG - Bulgaria 146
TG - Togo 130
NG - Nigeria 83
CI - Costa d'Avorio 81
JO - Giordania 77
SC - Seychelles 73
CH - Svizzera 63
BE - Belgio 60
FI - Finlandia 54
JP - Giappone 43
NL - Olanda 34
GR - Grecia 29
TR - Turchia 29
BR - Brasile 26
CA - Canada 25
IR - Iran 25
ES - Italia 22
PL - Polonia 22
SG - Singapore 21
RO - Romania 19
AT - Austria 17
CL - Cile 17
CZ - Repubblica Ceca 17
KR - Corea 15
LB - Libano 15
UZ - Uzbekistan 14
IL - Israele 11
AU - Australia 10
HK - Hong Kong 9
SY - Repubblica araba siriana 9
EG - Egitto 8
HR - Croazia 8
ID - Indonesia 8
MY - Malesia 8
PK - Pakistan 8
DK - Danimarca 7
KZ - Kazakistan 7
PH - Filippine 7
BD - Bangladesh 6
KE - Kenya 6
MD - Moldavia 6
NP - Nepal 6
HU - Ungheria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LK - Sri Lanka 4
MX - Messico 4
PE - Perù 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
LT - Lituania 3
NO - Norvegia 3
OM - Oman 3
PT - Portogallo 3
SA - Arabia Saudita 3
SI - Slovenia 3
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
IQ - Iraq 2
PA - Panama 2
AR - Argentina 1
EC - Ecuador 1
EU - Europa 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SN - Senegal 1
TW - Taiwan 1
Totale 31.935
Città #
Southend 3.341
Fairfield 2.590
Ashburn 1.414
Woodbridge 1.268
Seattle 1.148
Wilmington 1.104
Chandler 1.051
Houston 1.040
Cambridge 908
Princeton 795
Dong Ket 678
Ann Arbor 676
Jacksonville 662
Dublin 482
Westminster 333
Nanjing 303
Padova 300
Berlin 274
Bologna 271
Saint Petersburg 161
San Diego 155
Sofia 145
Shenyang 142
Turin 132
Jinan 131
Lomé 130
Mülheim 120
Hebei 97
Milan 97
Nanchang 93
New York 90
Beijing 89
Redmond 83
Abeokuta 82
Abidjan 81
Boardman 80
Medford 79
Amman 77
Changsha 74
Falls Church 74
Des Moines 70
Mahé 70
Tianjin 67
Brussels 60
Verona 60
Rome 53
Helsinki 51
Dearborn 50
Norwalk 47
Jiaxing 46
Redwood City 46
Olalla 41
Tokyo 41
Bremen 39
Ningbo 39
Zhengzhou 38
Bern 34
Haikou 33
Los Angeles 32
Bühl 31
Hangzhou 30
Menlo Park 30
London 29
Lanzhou 25
Naples 25
Kunming 24
Paris 23
Taizhou 22
Chicago 19
Florence 19
San Venanzo 19
Taiyuan 19
Bari 17
Pune 16
Washington 16
Fuzhou 14
Guangzhou 14
Frankfurt am Main 13
Istanbul 13
Buffalo 12
Hefei 12
Phoenix 12
Plauen 12
Singapore 12
Andover 11
São Paulo 11
Frankfurt Am Main 10
Muizenberg 9
Trento 9
Amsterdam 8
Den Haag 8
Falkenstein 8
Kuban 8
Modena 8
Palermo 8
San Francisco 8
Toronto 8
Edinburgh 7
Groningen 7
Lausanne 7
Totale 22.380
Nome #
Il diabete con epatopatia 480
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease 478
Quanto mangio veramente? 270
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease 218
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 198
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 190
Prevalence of Sexual Dysfunction among Postmenopausal Women with and without Metabolic Syndrome. 171
NAFLD e cirrosi epatica 165
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease 161
A combined HPLC-immunoenzymatic comprehensive screening for suspected drug poisoning in the emergency department 158
Predicting Frailty Condition in Elderly Using Multidimensional Socioclinical Databases 157
A standard ballroom and Latin dance program to improve fitness and adherence to physical activity in individuals with type 2 diabetes and in obesity 155
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 155
Cognitive-behavioral strategies to increase the adherence to exercise in the management of obesity 155
Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy 151
Double-heterozygous mutations involving both HNF1A (MODY3) and HNF4A (MODY1) genes: a case report 150
A randomized controlled trial of metformin vs. vitamin E or prescriptive diet in non-alcoholic fatty liver disease 147
Nonalcoholic fatty liver and insulin resistance: a cause-effect relationship? 146
A controlled, class-based multicomponent intervention to promote healthy lifestyle and to reduce the burden of childhood obesity 143
A position statement on NAFLD/NASH based on the EASL 2009 special conference 142
A randomized trial of energy-restricted high-protein versus high-carbohydrate, low-fat diet in morbid obesity. 140
Non-alcoholic fatty liver disease/Non-alcoholic steatohepatitis (NAFLD/NASH): treatment 139
The Role of Medications for the Management of Patients with NAFLD 138
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 138
Non-alcoholic steatohepatitis in patients cared in metabolic units 137
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 137
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial 136
Reply to: “Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients” 131
Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study 131
AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. 131
Comparison of WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes 131
Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting 130
Are behavioral approaches feasible and effective in type 2 diabetes? A propensity score analysis 129
The metabolic syndrome in treatment-seeking obese persons 128
Biomechanical and functional alterations in the diabetic foot: Differences between type I and type II Diabetes 128
Approcci nutrizionali nella steatoepatite non alcolica 128
Weight cycling in treatment-seeking obese persons. Data from the QUOVADIS study 127
A physical activity program to reinforce weight maintenance following a bheavior program in overweight/obese subjects. 127
Psychological status and depression in patients with liver cirrhosis 126
Prospective validation of a proposal for diagnosis and management of patients attending the emergency department for mild head injury 125
Behavioral aspects of nonalcoholic fatty liver disease: diet, causes, and treatment 125
Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones: A Disproportionality Analysis of the US FDA Adverse Event Reporting System Database. 125
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers 123
null 122
Emotional intelligence, emotion regulation and affectivity in adults seeking treatment for obesity. 122
Long-term weight loss maintenance for obesity: A multidisciplinary approach 121
Supervised vs. self-selected physical activity for individuals with diabetes and obesity: the Lifestyle Gym program 120
Correlation between DXA and laboratory parameters in normal weight, overweight, and obese patients 120
Venesection for nonalcoholic fatty liver disease unresponsive to lifestyle counselling - a propensity score-adjusted observational study 118
Coagulopathy and NICE recommendations for patients with mild head injury 116
Effects of cognitive-behavioral treatment for weight loss in the family members 116
Sexuality and psychopathological aspects in premenopausal women with metabolic syndrome. 116
Compulsive exercise to control shape or weight in eating disorders: Prevalence, associated features and treatment outcome 116
Effects of cognitive-behavioral therapy on eating disorders: neurotransmitter secretory response to treatment 115
Acute heart failure in the emergency department: a follow-up study 115
Psychological distress in morbid obesity in relation to weight history 114
Self-Induced vomiting in eating disorders: associated features and treatment outcome 113
A 360-degree overview of body composition in healthy people: Relationships among anthropometry, ultrasonography, and dual-energy x-ray absorptiometry 113
Prevalenza delle disfunzioni sessuali femminili nelle donne in menopausa con sindrome metabolica. 113
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? 113
Therapeutic hypothermia after cardiac arrest: The Mediterranean-diet Italian style 112
A psychological support program for individuals with type 1 diabetes 112
Weight loss expectations in obese patients seeking treatment at medical centers 111
The construct validity of the Short Form-36 health survey and its relationship with BMI in obese outpatients 111
Predictors of health-related quality of life in patients with chronic liver disease 111
Insulin resistance in nonalcoholic fatty liver disease 111
Treatment of nonalcoholic fatty liver with focus on emerging drugs 111
Cognitive-behavioral treatment of nonalcoholic fatty liver disease: a propensity score-adjusted observational study 111
Impaired Lipid Profile is a Risk Factor for the Development of Sexual Dysfunction in Women 108
DXA-assessed changes in body composition in obese women following two different weight loss programs 108
Composizione corporea: studio di normalità 107
Clinical and psychological correlates of health-related quality of life in obese patients 107
Acute Heart Failure in the Emergency Department: the SAFE-SIMEU Epidemiological Study 107
Update on nutritional supplementation with branched-chain amino acids 105
Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver 105
Massive weight loss without surgery in a super obese patient 104
Risk of malnutrition (over and under-nutrition): Validation of the JaNuS screening tool 104
Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study 104
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD 103
Nonalcoholic fatty liver disease: Disease and comorbidity--effects on quality of life 103
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver? 103
Analysis of different decision aids for clinical use in pediatric head injury in an emergency department of a general hospital 103
Metabolic Syndrome and NASH 102
Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study 102
Metabolic syndrome in liver transplantation. Relation to etiology and immunosuppression 102
The effect of obesity management on body image in patients seeking treatment at medical centers 101
Lifestyle changes for the treatment of nonalcoholic fatty liver disease-a 2015-19 update 101
Diabetes and hepatocellular cancer risk: not only a matter of hyperglycemia 100
Weight Loss Expectations and Attrition in Treatment-Seeking Obese Women 100
ICD code retrieval: Novel approach for assisted disease classification 100
Physical activity support or weight loss counseling for nonalcoholic fatty liver disease? 100
Psychological profile and quality of life of morbid obese patients attending a cognitive behavioural program 99
Obesity-associated liver disease 99
Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study 99
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study 98
Symptoms of starvation in eating disorder patients 98
Which treatment for nonalcoholic fatty liver disease? 98
Anthropometry and nutritional rehabilitation in underweight eating disorders 98
Which type of observation for patients with high-risk mild head injury and negative computed tomography? 97
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C 97
Totale 13.135
Categoria #
all - tutte 77.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.000 0 0 0 0 0 0 0 0 0 419 166 415
2019/20209.931 1.296 228 174 585 1.063 1.037 1.261 1.381 1.301 671 325 609
2020/20215.384 1.085 446 178 311 163 427 172 292 425 333 282 1.270
2021/20226.150 612 229 456 457 679 371 171 470 242 263 1.150 1.050
2022/20235.985 685 818 315 736 420 394 253 330 1.010 178 531 315
2023/20241.807 133 318 117 148 159 360 136 194 82 160 0 0
Totale 32.646